All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • Chengdu Zenitar Biomedical Technology Co., Ltd · Advanced Solid Tumor

  • B013Phase 21 trial

    Shanghai Jiaolian Drug Research and Development Co., Ltd · Platinum-resistant Recurrent Ovarian Cancer

  • B2065Phase 21 trial

    Tasly Pharmaceutical Group Co., Ltd · Acute Ischemic Stroke

  • B244Phase 21 trial

    AOBiome LLC · Acne Vulgaris

  • BalstililmabPhase 21 trial

    Nelum Corp · Untreated, Advanced Pancreatic Cancer

  • BAT1006Phase 21 trial

    Bio-Thera Solutions · Advanced Solid Tumors

  • BAT8008Phase 21 trial

    Bio-Thera Solutions · Advanced Solid Tumors

  • BAT8010Phase 21 trial

    Bio-Thera Solutions · Advanced Solid Tumors

  • BAY 3401016Phase 21 trial

    Bayer · Alport Syndrome

  • BAY 3670549Phase 21 trial

    Bayer · Atrial Fibrillation

  • BAY 3713372Phase 21 trial

    Bayer · MTAP-deleted Solid Tumors

  • BAY2599023DTX201Phase 21 trial

    Bayer · Hemophilia A

  • BAY3018250Phase 21 trial

    Bayer · Thrombolysis, Symptomatic Proximal Deep Vein Thrombosis

  • BAY3283142Phase 21 trial

    Bayer · Chronic Kidney Disease

  • BB-031DTRI-031Phase 21 trial

    Basking Biosciences, Inc. · Acute Ischemic Stroke

  • BB-101Phase 21 trial

    Blue Blood Biotech Corp. · Diabetic Foot Ulcer

  • BB-1701Phase 21 trial

    Eisai · Breast Cancer

  • BB102Phase 21 trial

    Broadenbio Ltd., Co. · Hepatocellular Carcinoma (HCC)

  • BBI-001Phase 21 trial

    Bond Biosciences · Hereditary Hemochromatosis

  • BBT-207Phase 21 trial

    Bridge Biotherapeutics, Inc. · EGFR Mutant Advanced Non-Small Cell Lung Cancer

  • BBT-877Phase 21 trial

    Bridge Biotherapeutics, Inc. · Idiopathic Pulmonary Fibrosis

  • BBT001Phase 21 trial

    Bambusa Therapeutics · Chronic Spontaneous Urticaria

  • BBT002Phase 21 trial

    Bambusa Therapeutics · Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

  • BC006Phase 21 trial

    Dragonboat Biopharmaceutical Company Limited · Idiopathic Pulmonary Fibrosis (IPF)

  • BC3195Phase 21 trial

    Biocity Biopharmaceutics Co., Ltd. · Locally Advanced or Metastatic Solid Tumors

  • BCB-276Phase 21 trial

    BrainChild Bio, Inc · Diffuse Intrinsic Pontine Glioma, DIPG, Brain Tumor

  • BCD-236Phase 21 trial

    Biocad · Triple Negative Breast Cancer

  • BDC-4182Phase 21 trial

    Bolt Biotherapeutics, Inc. · Gastric Cancer Adenocarcinoma Metastatic, Gastroesophageal Adenocarcinoma

  • BEAM-101Phase 21 trial

    Beam Therapeutics Inc. · Sickle Cell Disease

  • BEAM-201Phase 21 trial

    Beam Therapeutics Inc. · Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia

  • BEAM-302Phase 21 trial

    Beam Therapeutics Inc. · Alpha 1-Antitrypsin Deficiency

  • BEBT-701Phase 21 trial

    BeBetter Med Inc · Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol

  • BemnifosbuvirAT-527Phase 21 trial

    Atea Pharmaceuticals, Inc. · Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C

  • BerubicinPhase 21 trial

    CNS Pharmaceuticals, Inc. · Glioblastoma Multiforme, Adult

  • BEY2153Phase 21 trial

    BeyondBio Inc. · Alzheimer Disease, Alzheimer' Disease

  • BFB-101AAV9-CBh-AP4B1Phase 21 trial

    BlackfinBio Ltd · HSP, Hereditary Spastic Paraplegia, Hereditary Spastic Paraparesis

  • BG1805Phase 21 trial

    Guangzhou Bio-gene Technology Co., Ltd · Leukemia, Myeloid, Acute

  • BGC101autologous EnEPC preparationPhase 21 trial

    Biogen · Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease

  • BGM1812plcaeboPhase 21 trial

    BrightGene Bio-Medical Technology Co., Ltd. · Overweight or Obese Participants Without Diabetes

  • BGP-014Phase 21 trial

    BioGaia Pharma AB · Ulcerative Colitis

  • BH-30643Phase 21 trial

    BlossomHill Therapeutics · NSCLC (Advanced Non-small Cell Lung Cancer)

  • BHB810Phase 21 trial

    BigHat Biosciences, Inc. · Gastric Cancer, Gastric Adenocarcinoma, Gastric (Stomach) Cancer

  • BHV-1510PBI-410, GQ1010Phase 21 trial

    Biohaven Therapeutics Ltd. · Solid Tumor

  • BHV-2100Phase 21 trial

    Biohaven Therapeutics Ltd. · Migraine

  • BI 1584862Phase 21 trial

    Boehringer Ingelheim · Geographic Atrophy

  • BI 1815368Phase 21 trial

    Boehringer Ingelheim · Macular Edema

  • BI 1819479Phase 21 trial

    Boehringer Ingelheim · Idiopathic Pulmonary Fibrosis

  • BI 3000202Phase 21 trial

    Boehringer Ingelheim · Systemic Lupus Erythematosus

  • BI 3032950Phase 21 trial

    Boehringer Ingelheim · Ulcerative Colitis

  • BI 3034701Phase 21 trial

    Boehringer Ingelheim · Obesity, Overweight

NewerPage 46 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.